Early stage ovarian cancer clinical behavior according to FIGO 2014 Staging changes with a focus on IC subtype: data from prospective GEICO registry.
Ignacio Romero(Valencian Infertility Institute), José María Del Campo, Ana Santaballa(Hospital Universitari i Politècnic La Fe), Cristina Churruca(Biogipuzkoa Health Research Institute), Ana B. Sánchez(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Isabel Bover(Hospital Universitari Sant Joan de Reus), Jerónimo Martínez(Hospital Universitario Virgen de la Arrixaca), Andrés Redondo(Hospital Universitario La Paz), José Antonio López‐Guerrero(Consejo Superior de Investigaciones Científicas), Núria Laínez(Complejo Hospitalario de Navarra), Andrés Poveda(Hospital Quirónsalud Barcelona), Ana Herrero(Hospital Universitario Miguel Servet), Elena García-Martínez(Hospital General Universitario Morales Meseguer), Ana De Juan(Marqués de Valdecilla University Hospital), Susana Hernando Polo(Hospital Universitario Fundación Alcorcón), E. Calvo(Hospital Universitario Virgen del Rocío), César Mendiola(Hospital Universitario 12 De Octubre), B. Ojeda(Apple (Israel)), Margarita Romeo(Institut Català d'Oncologia), Cristina Caballero(Hospital General Universitario De Valencia)
Cited by 1
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
|New England Journal of Medicine|2009|2.4k
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k